This section covers treatment of ITP in special populations including surgical patients, ITP in pregnancy (mother and fetus) and patients with refractory ITP.

Note: WinRho SDF is not labelled for treatment of these special populations.  The data presented in the following pages reflect up to date, scientific evidence of the pathophysiology of the conditions. Treatment recommendations are not claimed for these special populations.

Personal Communication. B. Garvey MD, FRCPC, Professor University of Toronto, Director Hematology St.Michael's Hospital, Toronto, Ontario, Canada